My HPRA: Register

PANADEINE

500/8 Milligram Tablets

GlaxoSmithKline Consumer Healthcare (Ireland) LimitedPA0678/026/001

Main Information

Trade NamePANADEINE
Active SubstancesPARACETAMOL
CODEINE PHOSPHATE
Strength500/8 Milligram
Dosage FormTablets
Licence HolderGlaxoSmithKline Consumer Healthcare (Ireland) Limited
Licence NumberPA0678/026/001

Group Information

ATC CodeN02AJ06 codeine and paracetamol

Status

Authorised/WithdrawnAuthorised
Licence Issued29/03/1993
Supply StatusSupply through pharmacies only
Dispensing StatusProduct not subject to medical prescription
Marketing StatusNot Marketed
Promotion StatusPromotion to Healthcare Professionals only
Conditions of LicenceRetail sale through pharmacies only in blister packs containing not more than 24 unit dosage forms. Not more than two such packs should be supplied in the course of any one retail transaction unless a valid prescription exists. Packs containing more than 24 unit dosage forms may be supplied to pha

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back
Follow medicine

Print

Summary of Product Characteristics

View More SPC Headings

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.